A novel far-red fluorescent xenograft model of ovarian carcinoma for preclinical evaluation of HER2-targeted immunotoxins.
about
Spheroids of HER2-Positive Breast Adenocarcinoma for Studying Anticancer Immunotoxins In Vitro.Bioreactor-Based Tumor Tissue Engineering.HER2-specific recombinant immunotoxin 4D5scFv-PE40 passes through retrograde trafficking route and forces cells to enter apoptosisDual bioluminescence and near-infrared fluorescence monitoring to evaluate spherical nucleic acid nanoconjugate activity in vivo.Recombinant Immunotoxin 4D5scFv-PE40 for Targeted Therapy of HER2-Positive Tumors
P2860
A novel far-red fluorescent xenograft model of ovarian carcinoma for preclinical evaluation of HER2-targeted immunotoxins.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A novel far-red fluorescent xe ...... of HER2-targeted immunotoxins.
@ast
A novel far-red fluorescent xe ...... of HER2-targeted immunotoxins.
@en
type
label
A novel far-red fluorescent xe ...... of HER2-targeted immunotoxins.
@ast
A novel far-red fluorescent xe ...... of HER2-targeted immunotoxins.
@en
prefLabel
A novel far-red fluorescent xe ...... of HER2-targeted immunotoxins.
@ast
A novel far-red fluorescent xe ...... of HER2-targeted immunotoxins.
@en
P2093
P2860
P356
P1433
P1476
A novel far-red fluorescent xe ...... of HER2-targeted immunotoxins
@en
P2093
Dmitry Karpenko
Evgeniya Sokolova
Oleg Stremovskiy
Sergey Deyev
Tatiana Zdobnova
William Telford
P2860
P304
30919-30928
P356
10.18632/ONCOTARGET.5130
P407
P577
2015-10-01T00:00:00Z